Posts

Webcast Helps Physicians Learn About Ocular Complications of Systemic Disease

OSUWexnerbloglogo2014 Webcast Helps Physicians Learn About Ocular Complications of Systemic Disease. It has been said that the eyes are the windows to the soul. That may or may not be true but the eyes can be the windows to disease. Sometimes, it is the ocular findings that are the first clue to an underlying systemic disease. Other times, a known systemic disease may alert the physician about the risks of important ocular complications. The ophthalmoscope allows you to examine structures you can’t otherwise see. For example, the retinal arteries are the only arteries that are easily visible non-invasively. Today on MedNet21, we’re going to see how the eye can be affected by many common systemic diseases. My guest is Assistant Professor of Ophthalmology, Dr. Carla Ford.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: discuss ocular findings
of common systemic diseases; and provide a brief overview of treatment options of ocular complications of systemic diseases.

You’ll also learn about the following:

  • Common systemic diseases affecting the eye
  • Central retinal vein occlusion
  • Migraine and the eye
  • Candidemia
  • HIV and the eye

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Get An Update on Antibiotics on CME Webcast

OSUWexnerbloglogo2014 Get An Update on Antibiotics on CME Webcast. Today on OSU MedNet, we are going to update you on some of these new antibiotics. Let me welcome today’s guest, Dr. Sydney Agnello. She is an infectious disease expert and Assistant Professor of Internal Medicine from the Ohio State University.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: enhance knowledge of clinical use of well-known antibiotics; and enhance understanding of newer antibiotics available and when they may be used clinically.

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

How to View a MedNet21 Webcast

Here’s how to view an OSU MedNet21 Webcast.

First, log into your CCME account.

Next, click the View Webcasts link as it appears above.

You can also click on the View Webcasts button that appears here.

 

On the new page that appears, scroll towards the bottom of the page, and click on the webcast you would like to view.  You can always find new webcasts on this page.

Once the page appears for the webcast, click the green View Webcast button at the bottom of the webcast page.

You should see a new page appear with a play button.  Click on the play button to watch the webcast.

 

The webcast should start playing.

To view or download presentation handouts, navigate back to the webcast page and click on the download button for the file that you would like download.

Update in Dermatology – 2    (This handout is two slides per page in black and white.)

Update in Dermatology – 4   (This handout is four slides per page in black and white.)

Update in Dermatology – 2 color (This handout is two slides per page in color.)

Once you finish watching the webcast, navigate back to the webcast page to take the post-test by clicking the Take Post-test button.

Learn How to Use Telemedicine in Your Clinical Practice

OSUWexnerbloglogo2014 Learn How to Use Telemedicine in Your Clinical Practice. Telemedicine is not new, in fact, we first did a program on telemedicine 20 years ago on OMEN-TV, the predecessor of MedNet. But with the COVID pandemic of the past year, telemedicine has been adopted by most physicians as a regular and normal part of their practice. However, with that comes the question of how can we most optimally use telemedicine? Today on MedNet, we’re going to update you on how you can most effectively apply telemedicine to your own clinical practice. Joining me today are two MedNet veterans from the Ohio State University. Dr. Shengyi Mao is an Assistant Professor of Internal Medicine and Pediatrics. And Dr. Nathan Richards is also an Assistant Professor of Internal Medicine and Pediatrics.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: recognize the benefits and limitations of telehealth; know which ailments are amenable to telehealth and which are not; be familiar with the different forms of telehealth; and understand the basics of a telehealth physical exam.

You’ll also learn about the following:

  • Telemedicine at the OSU Wexner Medical Center
  • Common barriers to using telemedicine
  • Telemedicine in the teaching setting
  • Inpatient use of telemedicine
  • Advance practice providers and telemedicine
  • Controlled substances and telemedicine
  • Telemedicine and nursing homes

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Physicians Learn About Multiple Myeloma and MGUS on Webcast

OSUWexnerbloglogo2014 Physicians Learn About Multiple Myeloma and MGUS. Today on MedNet, we’re going to update you on the newest developments in the management of multiple myeloma. We’re pleased to welcome Assistant Professor of Internal Medicine, Dr. Srinivas Devarakonda.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: explain the clinical scenarios in which to suspect multiple myeloma; Explain the diagnostic methods for multiple myeloma; discuss the latest diagnostic criteria and staging system for multiple myeloma; and describe the management of myeloma.

You’ll also learn about the following:

  • Multiple myeloma demographics
  • Multiple myeloma prognosis
  • Evaluation of MGUS
  • When to replace patients with IgG
  • Screening for multiple myeloma
  • Waldenstrom’s macroglobulinemia
  • Kappa versus lambda light chains
  • Future directions in treatment

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.